Company / Assets per Share
ROCKET PHARMACEUTICALS, INC. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$3.10
FY2025
5-year range
$3.10 / $8.55
FY2021-FY2025
Trend
-46.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 3 consecutive years, from $8.55 in FY2022 to $3.10 in FY2025.
Based on SEC 10-K filings.
3.10 in FY2025 with a 5-year CAGR of -22.1%.
Declined from $7.16 to $3.10 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -28.7%
- 5-Year CAGR
- -22.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 46.9% year-over-year.
- Peak assets per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.10 | -46.9% |
| FY2024 | $5.85 | -18.3% |
| FY2023 | $7.16 | -16.3% |
| FY2022 | $8.55 | +5.0% |
| FY2021 | $8.15 | -24.5% |
| FY2020 | $10.79 | +30.9% |
| FY2019 | $8.24 | -77.7% |
| FY2018 | $36.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026